Sight Sciences (SGHT) grants $130K in RSUs to board director

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Burbach Gerhard F reported acquisition or exercise transactions in this Form 4 filing.

Sight Sciences, Inc. reported that director Gerhard F. Burbach received a grant of 28,261 restricted stock units (RSUs) under the company’s Non-Employee Director Compensation Program. The award equals approximately $130,000 of common stock based on the closing price on June 4, 2026.

The RSUs vest on the earlier of June 4, 2027 or the company’s 2027 annual stockholder meeting, if he continues serving as a director through that date. Following this grant, he directly holds a total of 123,207 common shares and RSUs, including 44,922 shares of common stock and RSUs from current and prior awards.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Burbach Gerhard F

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	28,261	$0.00	--

Holdings After Transaction: Common Stock — 123,207 shares (Direct, null)

Footnotes (1)

Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 4, 2026. The RSUs vest on the earlier of June 4, 2027 and the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date. Includes (i) 44,922 shares of Common Stock, (ii) 28,261 RSUs which are subject to vesting as reported herein, and (iii) 49,844 RSUs granted to the Reporting Person on 5/12/2025 which are subject to vesting as previously reported.

Key Figures

RSUs granted: 28,261 RSUs Grant value: approximately $130,000 Total holdings after grant: 123,207 shares/RSUs +3 more

6 metrics

RSUs granted 28,261 RSUs Non-Employee Director Compensation Program grant on June 4, 2026

Grant value approximately $130,000 Value of RSUs based on closing price on June 4, 2026

Total holdings after grant 123,207 shares/RSUs Direct holdings following the June 4, 2026 RSU award

Common stock held 44,922 shares Outstanding common shares held directly by the director

Prior RSU award 49,844 RSUs RSUs granted on May 12, 2025, still subject to vesting

Vesting date earlier of June 4, 2027 or 2027 annual meeting Condition for vesting of newly granted RSUs

Key Terms

restricted stock units ("RSUs"), Non-Employee Director Compensation Program, vest, contingent right, +1 more

5 terms

restricted stock units ("RSUs") financial

"Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Non-Employee Director Compensation Program financial

"made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program"

vest financial

"The RSUs vest on the earlier of June 4, 2027 and the date of the Issuer's 2027 annual meeting"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

contingent right financial

"Each RSU represents a contingent right to receive one share of the Issuer's common stock"

annual meeting of stockholders financial

"the date of the Issuer's 2027 annual meeting of stockholders"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/05/2026 - 04:10 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burbach Gerhard F

(Last)

(First)

(Middle)

C/O SIGHT SCIENCES, INC.

4040 CAMPBELL AVE., SUITE 100

(Street)

MENLO PARK

CALIFORNIA

94025

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sight Sciences, Inc. [ SGHT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/04/2026		A		28,261⁽¹⁾	A	$0.00	123,207⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 4, 2026. The RSUs vest on the earlier of June 4, 2027 and the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date.

2. Includes (i) 44,922 shares of Common Stock, (ii) 28,261 RSUs which are subject to vesting as reported herein, and (iii) 49,844 RSUs granted to the Reporting Person on 5/12/2025 which are subject to vesting as previously reported.

	/s/Jeremy Hayden, Attorney-in-Fact for Gerhard Burbach	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Sight Sciences (SGHT) disclose about director Gerhard Burbach’s new award?

Sight Sciences disclosed that director Gerhard F. Burbach received 28,261 restricted stock units as part of its Non-Employee Director Compensation Program. These RSUs were valued at approximately $130,000 based on the June 4, 2026 closing price of the company’s common stock.

How many RSUs did Sight Sciences grant to Gerhard Burbach and what is their value?

Sight Sciences granted Gerhard F. Burbach 28,261 restricted stock units, equal to about $130,000 of common stock. The value was determined using the company’s closing stock price on June 4, 2026, the date the grant was made under the director compensation program.

When do Gerhard Burbach’s new Sight Sciences RSUs vest?

The 28,261 RSUs granted to Gerhard F. Burbach vest on the earlier of June 4, 2027 or Sight Sciences’ 2027 annual meeting of stockholders. Vesting is conditioned on his continued service as a director on the company’s board through that vesting date.

How many Sight Sciences shares and RSUs does Gerhard Burbach hold after this grant?

After this grant, Gerhard F. Burbach directly holds 123,207 shares and RSUs of Sight Sciences common stock. This includes 44,922 common shares, 28,261 newly granted RSUs, and 49,844 RSUs from a prior award granted on May 12, 2025, all subject to applicable vesting.

Is Gerhard Burbach’s new RSU grant from Sight Sciences an open-market purchase?

No. The 28,261 RSUs are a compensation grant, not an open-market purchase. They were awarded under Sight Sciences’ Non-Employee Director Compensation Program at no cash cost per unit, providing a contingent right to receive common stock upon vesting conditions being satisfied.